We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.56%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$1.79B
(+14%)
Cap. Flow
+$849M
Cap. Flow
% of AUM
5.76%
Top 10 Holdings %
Top 10 Hldgs %
16.89%
Holding
1,178
New
178
Increased
473
Reduced
324
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$128M |
| 2 |
Intel
INTC
|
+$88.4M |
| 3 |
Prudential Financial
PRU
|
+$72.7M |
| 4 |
Lam Research
LRCX
|
+$62.6M |
| 5 |
SBA Communications
SBAC
|
+$58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$98.3M |
| 2 |
Target
TGT
|
+$86.8M |
| 3 |
Occidental Petroleum
OXY
|
+$74.7M |
| 4 |
Synchrony
SYF
|
+$61.6M |
| 5 |
Intercontinental Exchange
ICE
|
+$57.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.69% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 13.08% |
| 4 | Consumer Discretionary | 12.97% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDCE
426
DELISTED
PDC Energy, Inc.
PDCE
| $5.1M | 0.03% |
111,293
+12,775
| +13% | +$522K |
|
427
Darling Ingredients
DAR
$9.56B
| $5.05M | 0.03% |
+74,862
| New | +$5.27M |
|
|
AAWW
428
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $5M | 0.03% |
73,465
+43,568
| +146% | +$3.05M |
|
|
TVRD
429
Tvardi Therapeutics
TVRD
$23M
| $4.99M | 0.03% |
9,713
-7,212
| -43% | -$4.57M |
|
|
NGM
430
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $4.99M | 0.03% |
252,823
+22,351
| +10% | +$523K |
|
431
V2X
VVX
$2.62B
| $4.98M | 0.03% |
104,615
-26,778
| -20% | -$1.38M |
|
432
Comscore
SCOR
$105M
| $4.94M | 0.03% |
49,385
+9,686
| +24% | +$759K |
|
433
Grand Canyon Education
LOPE
$3.78B
| $4.89M | 0.03% |
+54,401
| New | +$5.38M |
|
434
Accenture
ACN
$94.2B
| $4.86M | 0.03% |
16,497
+15,495
| +1,546% | +$4.44M |
|
435
American International
AIG
$42.4B
| $4.86M | 0.03% |
+102,121
| New | +$5.05M |
|
436
Carriage Services
CSV
$632M
| $4.86M | 0.03% |
131,488
+63,303
| +93% | +$2.36M |
|
437
Wendy's
WEN
$1.4B
| $4.86M | 0.03% |
207,437
+49,694
| +32% | +$1.14M |
|
438
HealthStream
HSTM
$801M
| $4.85M | 0.03% |
173,592
+8,740
| +5% | +$220K |
|
|
KBAL
439
DELISTED
Kimball International
KBAL
| $4.84M | 0.03% |
367,879
+54,548
| +17% | +$743K |
|
|
RAD
440
DELISTED
Rite Aid Corporation
RAD
| $4.8M | 0.03% |
294,386
-131,325
| -31% | -$2.51M |
|
441
Ribbon Communications
RBBN
$356M
| $4.78M | 0.03% |
628,475
+189,221
| +43% | +$1.45M |
|
442
Hilltop Holdings
HTH
$2.28B
| $4.78M | 0.03% |
131,258
-42,853
| -25% | -$1.53M |
|
|
TBRG
443
DELISTED
TruBridge
TBRG
| $4.77M | 0.03% |
143,673
+11,325
| +9% | +$359K |
|
444
Vanda Pharmaceuticals
VNDA
$318M
| $4.77M | 0.03% |
221,634
-486,854
| -69% | -$8.71M |
|
|
RDUS
445
DELISTED
Radius Recycling
RDUS
| $4.63M | 0.03% |
94,375
-67,223
| -42% | -$3.34M |
|
446
Moog Inc Class A
MOG.A
$13B
| $4.61M | 0.03% |
54,857
+6,859
| +14% | +$593K |
|
447
Heron Therapeutics
HRTX
$88.8M
| $4.58M | 0.03% |
295,276
-347,199
| -54% | -$5.52M |
|
448
DigitalBridge
DBRG
$2.94B
| $4.57M | 0.03% |
+144,483
| New | +$4.13M |
|
|
CPRX
449
DELISTED
Catalyst Pharmaceutical
CPRX
| $4.54M | 0.03% |
790,149
-348,462
| -31% | -$1.8M |
|
|
LL
450
DELISTED
LL Flooring Holdings, Inc.
LL
| $4.54M | 0.03% |
215,016
+143,273
| +200% | +$3.37M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2021 Portfolio in Review
As of Q2 2021, Jacobs Levy Equity Management held 1,178 positions worth $14.8B, up 14% from $13B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $849M of net new capital in Q2 2021, opening 178 new positions and adding to 473 existing holdings. Its largest new stake was Lam Research: 991,120 shares worth $64.5M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Qualcomm, an estimated $98.3M trimmed.
- Jacobs Levy Equity Management's largest Q2 2021 buy was Lam Research: 991,120 shares worth $64.5M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q2 2021, an estimated $128M increase.
- Jacobs Levy Equity Management's biggest Q2 2021 reduction was Qualcomm, cutting an estimated $98.3M.
- Jacobs Levy Equity Management fully exited Occidental Petroleum in Q2 2021, selling an estimated $74.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q2 2021.
- Jacobs Levy Equity Management opened 178 new positions and closed 161 in Q2 2021.
- Jacobs Levy Equity Management's portfolio value rose 14% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2021, filed 16 Aug 2021.